Mesa Laboratories (MLAB) Equity Ratio (2011 - 2025)

Mesa Laboratories has disclosed Equity Ratio across 15 years of filings, most recently posting 0.43 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.43, up 19.86% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.43 (up 19.86% YoY), and the FY2025 annual result was 0.37, up 13.34% from the prior year.
• Equity Ratio came in at 0.43 for Q4 2025 at Mesa Laboratories, up from 0.41 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.68 in Q1 2021 to a low of 0.33 in Q1 2024.
• The 5-year median for Equity Ratio is 0.55 (2021), against an average of 0.51.
• Across the five-year window, Equity Ratio climbed 25.59% in 2021 and slumped 45.27% in 2024, its largest moves.
• Mesa Laboratories' Equity Ratio stood at 0.55 in 2021, then advanced by 6.35% to 0.58 in 2022, then declined by 6.98% to 0.54 in 2023, then tumbled by 34.07% to 0.36 in 2024, then gained by 19.86% to 0.43 in 2025.
• The last three Equity Ratio figures came in at 0.43 (Q4 2025), 0.41 (Q3 2025), and 0.4 (Q2 2025), per Business Quant data.